多囊卵巢综合症(polycystic ovary syndrome, PCOS)是妇科临床常见的内分泌疾病,发病率可达5%~10%。青春期PCOS病因尚未明确,通常表现为青春期人群月经紊乱、雄激素过多症和肥胖等。然而,证据表明青春期多囊卵巢综合征是遗传和环境因素相互作用所致。若不及时采取正确的诊断与治疗,会进一步导致青春期PCOS患者肥胖、多毛、痤疮、月经不调等,远期可能发生不孕及2型糖尿病、高血压、子宫内膜癌等,从而加重此类患者社会及心理负担。现将青春期PCOS的病因和治疗新进展予以综述,以期为临床治疗提供有力的依据。 Polycystic ovary syndrome (PCOS) is a common endocrine disease in gynecology clinic, with an in-cidence of 5% - 10%. The etiology of adolescent PCOS is not yet clear, usually manifested as men-strual disorders, androgens and obesity in adolescents. However, evidence suggests that adolescent polycystic ovary syndrome is caused by the interaction of genetic and environmental factors. If the correct diagnosis and treatment are not taken in time, it will further lead to obesity, hirsutism, acne and irregular menstruation in adolescent PCOS patients. In the long run, infertility and type 2 diabetes mellitus, hypertension, endometrial cancer may occur, thus aggravating the social and psychological burden of such patients. This article reviews the etiology and treatment of adolescent PCOS in order to provide a strong basis for clinical treatment.
杨克敏,柳 露,金天福,李 芹. 青春期多囊卵巢综合症的病因及治疗进展Etiology and Treatment Progress of Adolescent Polycystic Ovary Syndrome[J]. 临床医学进展, 2019, 09(08): 986-993. https://doi.org/10.12677/ACM.2019.98150
参考文献References
Rosenfield, R.L. and Ehrmann, D.A. (2016) The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews, 37, 467-520.
https://doi.org/10.1210/er.2015-1104
Franks, S. (2008) Polycystic Ovary Syndrome in Adolescents. International Journal of Obesity, 32, 1035.
https://doi.org/10.1038/ijo.2008.61
Burghen, G.A., Givens, J.R. and Kitabchi, A.E. (1980) Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease. The Journal of Clinical Endocrinology & Metabolism, 50, 113-116.
https://doi.org/10.1210/jcem-50-1-113
Chang, R.J., Nakamura, R.M., Judd, H.L., et al. (1983) Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease. The Journal of Clinical Endocrinology & Metabolism, 57, 356-359.
https://doi.org/10.1210/jcem-57-2-356
Dunaif, A., Segal, K.R., Shelley, D.R., et al. (1992) Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome. Diabetes, 41, 1257-1266.
https://doi.org/10.2337/diab.41.10.1257
Ehrmann, D.A., Sturis, J., Byrne, M.M., et al. (1995) Insulin Secretory Defects in Polycystic Ovary Syndrome. Relationship to Insulin Sensitivity and Family History of Non-Insulin-Dependent Diabetes Mellitus. The Journal of Clinical Investigation, 96, 520-527.
https://doi.org/10.1172/JCI118064
Nestler, J.E. (1997) Insulin Regulation of Human Ovarian Androgens. Human Reproduction, 12, 53-62.
https://doi.org/10.1093/humrep/12.suppl_1.53
Anderson, A.D., Solorzano, C.M.B. and McCartney, C.R. (2014) Childhood Obesity and Its Impact on the Development of Adolescent PCOS. Seminars in Reproductive Medicine, 32, 202-213.
https://doi.org/10.1055/s-0034-1371092
McCartney, C.R., Blank, S.K., Prendergast, K.A., et al. (2006) Obesity and Sex Steroid Changes across Puberty: Evidence for Marked Hyperandrogenemia in Pre- and Early Pubertal Obese Girls. The Journal of Clinical Endocrinology & Metabolism, 92, 430-436.
https://doi.org/10.1210/jc.2006-2002
McCartney, C.R., Prendergast, K.A., Chhabra, S., et al. (2006) The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism, 91, 1714-1722.
https://doi.org/10.1210/jc.2005-1852
Reinehr, T., de Sousa, G., Roth, C.L., et al. (2005) Androgens before and after Weight Loss in Obese Children. The Journal of Clinical Endocrinology & Metabolism, 90, 5588-5595.
https://doi.org/10.1210/jc.2005-0438
Rojas, J., Chávez, M., Olivar, L., et al. (2014) Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. International Journal of Reproductive Medicine, 2014, Article ID: 719050.
https://doi.org/10.1155/2014/719050
Wilroy, R.S., Givens, J.R., Wiser, W.L., et al. (1975) Hyperthecosis, an Inheritance Form of Polycystic Ovary. I. Clinical and Histologic Features. The Journal of Clinical Endocrinology & Metabolism, 22, 326-328.
Zhao, H., Lv, Y., Li, L., et al. (2016) Genetic Studies on Polycystic Ovary Syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology, 37, 56-65.
https://doi.org/10.1016/j.bpobgyn.2016.04.002
Azziz, R., Carmina, E., Chen, Z., et al. (2016) Polycystic Ovary Syndrome. Nature Reviews Disease Primers, 2, 16057.
https://doi.org/10.1038/nrdp.2016.58
Rutkowska, A.Z. and Diamanti-Kandarakis, E. (2016) Polycystic Ovary Syndrome and Environmental Toxins. Fertility and Sterility, 106, 948-958.
https://doi.org/10.1016/j.fertnstert.2016.08.031
Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., et al. (2009) Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocrine Reviews, 30, 293-342.
https://doi.org/10.1210/er.2009-0002
Bolognesi, C., Castle, L., Cravedi, J.P., et al. (2015) Scientific Opinion on the Risks to Public Health Related to the Presence of Bisphenol A (BPA) in Foodstuffs: Executive Summary. EFSA Journal, 13, 3978.
Testai, E. (2016) The Safety of Medical Devices Containing DEHP Plasticized PVC or Other Plasticizers on Neonates and Other Groups Possibly at Risk (2015 Update). Regulatory Toxicology and Pharmacology: RTP, 76, 209.
https://doi.org/10.1016/j.yrtph.2016.01.013
Takeuchi, T., Tsutsumi, O., Ikezuki, Y., et al. (2004) Positive Relationship between Androgen and the Endocrine Disruptor, Bisphenol A, in Normal Women and Women with Ovarian Dysfunction. Endocrine Journal, 51, 165-169.
https://doi.org/10.1507/endocrj.51.165
Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., et al. (2008) Increased Serum Advanced Glycation End-Products Is a Distinct Finding in Lean Women with Polycystic Ovary Syndrome (PCOS). Clinical Endocrinology, 69, 634-641.
https://doi.org/10.1111/j.1365-2265.2008.03247.x
Nelson, V.L., Legro, R.S., Strauss III, J.F., et al. (1999) Augmented Androgen Production Is a Stable Steroidogenic Phenotype of Propagated Theca Cells from Polycystic Ovaries. Molecular Endocrinology, 13, 946-957.
https://doi.org/10.1210/mend.13.6.0311
de Faria, F.R., Gusmão, L.S., de Faria, E.R., et al. (2013) Polycystic Ovary Syndrome and Intervening Factors in Adolescents from 15 to 18 Years Old. Revista da Associação Médica Brasileira (English Edition), 59, 341-346.
https://doi.org/10.1016/S2255-4823(13)70485-5
Stracquadanio, M. and Ciotta, L. (2017) Low Birth-Weight Is a PCOS Risk Factor for Southern-Italian Women. Gynecological Endocrinology, 33, 373-377.
https://doi.org/10.1080/09513590.2017.1283487
Pandolfi, C., Zugaro, A., Lattanzio, F., et al. (2008) Low Birth Weight and Later Development of Insulin Resistance and Biochemical/Clinical Features of Polycystic Ovary Syndrome. Metabolism, 57, 999-1004.
https://doi.org/10.1016/j.metabol.2008.02.018
Domecq, J.P., Prutsky, G., Mullan, R.J., et al. (2013) Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 98, 4655-4663.
https://doi.org/10.1210/jc.2013-2385
Cattrall, F.R. and Healy, D.L. (2004) Long-Term Metabolic, Cardiovascular and Neoplastic Risks with Polycystic Ovary Syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology, 18, 803-812.
https://doi.org/10.1016/j.bpobgyn.2004.05.005
Legro, R.S., Arslanian, S.A., Ehrmann, D.A., et al. (2013) Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 98, 4565-4592.
https://doi.org/10.1210/jc.2013-2350
Orio, F., Muscogiuri, G., Giallauria, F., et al. (2016) Oral Contraceptives versus Physical Exercise on Cardiovascular and Metabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial. Clinical Endocrinology, 85, 764-771.
https://doi.org/10.1111/cen.13112
Hoeger, K., Davidson, K., Kochman, L., et al. (2008) The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials. The Journal of Clinical Endocrinology & Metabolism, 93, 4299-4306.
https://doi.org/10.1210/jc.2008-0461
Lass, N., Kleber, M., Winkel, K., et al. (2011) Effect of Lifestyle Intervention on Features of Polycystic Ovarian Syndrome, Metabolic Syndrome, and Intima-Media Thickness in Obese Adolescent Girls. The Journal of Clinical Endocrinology & Metabolism, 96, 3533-3540.
https://doi.org/10.1210/jc.2011-1609
Powers, B.J., Brown, G., Williams, R.W., et al. (2015) Medical Eligibility Criteria for Contraceptive Use. World Health Organization, 87, 276.
Cassidenti, D.L., Paulson, R.J., Serafini, P., et al. (1991) Effects of Sex Steroids on Skin 5 Alpha-Reductase Activity in Vitro. Obstetrics and Gynecology, 78, 103-107.
Gerlinger, C. and Heithecker, R. (2002) The Effect of 2 Combined Oral Contraceptives Containing Either Drospirenone or Cyproterone Acetate on Acne and Seborrhea. Cutis, 69, 2-15.
中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国治疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6.
Natali, A. and Ferrannini, E. (2006) Effects of Metformin and Thiazolidinediones on Suppression of Hepatic Glucose Production and Stimulation of Glucose Uptake in Type 2 Diabetes: A Systematic Review. Diabetologia, 49, 434-441.
https://doi.org/10.1007/s00125-006-0141-7
Foretz, M., Guigas, B., Bertrand, L., et al. (2014) Metformin: From Mechanisms of Action to Therapies. Cell Metabolism, 20, 953-966.
https://doi.org/10.1016/j.cmet.2014.09.018
Gooding, H.C., Milliren, C., Paul, M.S., et al. (2014) Diagnosing Dysglycemia in Adolescents with Polycystic Ovary Syndrome. Journal of Adolescent Health, 55, 79-84.
https://doi.org/10.1016/j.jadohealth.2013.12.020
Speroff, L. and Fritz, M.A. (2005) Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins, Philadelphia.
Mazza, A., Fruci, B., Guzzi, P., et al. (2014) In PCOS Patients the Addition of Low-Dose Spironolactone Induces a More Marked Reduction of Clinical and Biochemical Hyperandrogenism than Metformin Alone. Nutrition, Metabolism and Cardiovascular Diseases, 24, 132-139.
https://doi.org/10.1016/j.numecd.2013.04.016
杨雪萍. 多囊卵巢综合征与肝肾相关说[J]. 河南中医, 2012, 32(2): 144-145.
张宁, 刘家义. 痰湿型多囊卵巢综合征临床及内分泌特征分析[J]. 辽宁中医药大学学报, 2010, 12(7): 27-29.
李国珍, 阿依努尔. 补肾活血化痰法治疗多囊卵巢综合征56例[J]. 新疆中医药, 2014, 32(2): 16-18.
褚娟红, 吴桂珠. 补肾化痰活血法治疗多囊卵巢综合症30例疗效观察[J]. 现代实用医学, 2014, 26(5): 619-620.
甘瑾. 补肾祛瘀化痰方联合达英——35治疗多囊卵巢综合征的疗效研究[J]. 中医药学报, 2017, 45(5): 85-87.
刘欢妹, 刘宇萌, 魏丹, 孟化. 代谢手术治疗肥胖型多囊卵巢综合征的meta分析[J]. 内蒙古医科大学学报, 2019, 41(2): 139-143.
Fitzgerald, D.A. and Baur, L. (2014) Bariatric Surgery for Severely Obese Adolescents. Paediatric Respiratory Reviews, 15, 227-230.
https://doi.org/10.1016/j.prrv.2014.06.001